Therapy for acute pelvic inflammatory disease: a critique of recent treatment trials.
Recent approaches to determine optimal antimicrobial treatment for acute pelvic inflammatory disease are reviewed. From this review, it is suggested that in future studies a randomized study design, with controls for known factors which influence prognosis, and a uniform objective scoring system for monitoring clinical response be used and long-term evaluation of tubal function be performed. Such studies are urgently needed if optimal therapy for pelvic inflammatory disease is to be defined.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007434:Intrauterine Devices / Q000706:statistics & numerical data; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy* / Q000382:microbiology; D012746:Sexual Abstinence
D000900:Anti-Bacterial Agents